Pennsylvania House committee advances two adult-use cannabis bills
Health Committee approves cultivation and retail framework bills after months of closed-door negotiations.

Low angle of famous landmark with iron bell located near monumental palace against sunset sky in nature in evening time
Committee Vote Moves Bills to House Floor
The House Health Committee approved HB 1420 and HB 1421 in a 14-9 party-line vote on May 29, sending both measures to the full chamber. HB 1420 establishes licensing tiers for cultivation facilities ranging from micro-cultivators at 5,000 square feet to large-scale operations at 50,000 square feet. HB 1421 creates a retail permit structure allowing existing medical dispensaries first-right-of-refusal on adult-use licenses. It caps total statewide retail permits at 500 for the first two years.
Committee Chair Rep. Dan Frankel (D-Allegheny) said the bills represent a compromise between social-equity advocates and the state's existing medical operators. Rep. Kathy Rapp (R-Warren), the ranking minority member, voted against both bills. She said the timeline for implementation—January 2027—isn't realistic given the Department of Health's current staffing constraints.
Revenue Projections and Tax Structure
The bills impose a 20% excise tax on wholesale cannabis transactions, projected to generate $400 million in the first full fiscal year. According to the House Appropriations Committee's fiscal note, 50% of revenue would fund public education, 25% would support municipal governments hosting retail operations, and 25% would capitalize a social-equity loan fund for applicants from communities with disproportionate cannabis-arrest rates.
The tax structure mirrors frameworks in Illinois and New Jersey, where wholesale excise taxes have outperformed retail sales taxes in revenue stability during the first three years of legalization.
The bills don't address home cultivation. An amendment proposed by Rep. Emily Kinkead (D-Allegheny) to allow four plants per adult was tabled by voice vote. Home-grow provisions would be considered in separate legislation later in the session, Frankel said.
Senate Outlook and Timing
Senate leadership hasn't committed to a floor vote on companion bills. The chamber's Law and Justice Committee hasn't scheduled hearings. Senate President Pro Tempore Kim Ward (R-Westmoreland) said in a May 28 statement that she opposes legalization but would allow a committee process if the bills reach the Senate. For full background on Pennsylvania's multi-year legalization debate, see the CannIntel topic hub on Pennsylvania cannabis legalization.
Gov. Josh Shapiro has signaled support for adult-use legalization since his 2023 inauguration but hasn't endorsed specific bill language. His administration's Department of Health is drafting proposed regulations for cultivation and testing standards, according to a May 15 memo obtained by CannIntel. Those regulations would take effect 180 days after the governor signs enabling legislation.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Seven House Democrats Demand IRS Issue 280E Cannabis Tax Guidance
Congressional letter pressures Treasury to clarify deduction rules amid ongoing Schedule III reclassification.

Federal Medical Marijuana Recognition Raises Implementation Questions
Agencies face regulatory gaps after historic policy shift acknowledges medical value.

Minnesota Home Grow Rights Face Federal Threat Under DEA Rescheduling Rule
DEA's proposed Schedule III rule could override state law allowing home cultivation for medical patients.
More from the newsroom

Stale Flower Cuts Dispensary Margins as Aging Inventory Forces Discounts
Slow-moving cannabis flower forces retailers into margin-killing markdowns, turning freshness into a financial control point.

Opioid Overdoses Decline After Marijuana Legalization, NORML Analysis Finds
New data analysis links legal cannabis markets to measurable reductions in fatal opioid poisonings.

Dutch Marengo Trial Leaves Convicted Drug Lord Without Counsel
Ridouan Taghi's appeal stalls as no Dutch attorney will represent the convicted kingpin after a decade of witness murders and lawyer arrests.